Principal Investigator: Alistair McGuire
Research Team: Huseyin Naci, Maximilian Salcher
Start Date: 01 October 2013
End Date: 30 September 2016
Keywords: cardiac treatment, image-based technology, congenital heart disease, clinical decision-making, health policy, health economics
CARDIOPROOF was a European-Commission FP7 funded project on congenital heart disease. LSE works alongside centres of excellence in cardiac treatment (German Heart Institute in Berlin; Great Ormond Street Hospital in London; and Ospedale Pediatrico Bambino Gesù in Rome) and world leaders in engineering and simulation modelling. LSE’s role in CARDIOPROOF was to undertake a randomised controlled experiment to assess how novel, image-based technology may impact clinical decision-making for patients with congenital heart conditions.
Salcher M, Naci H, Law T, Kuehne T, Schubert S, Kelm M, Cardioproof Consortium. Balloon Dilatation and Stenting for Aortic Coarctation: A Systematic Review and Meta-Analysis. Circulation: Cardiovascular Interventions. 2016;9:e003153. doi:10.1161/CIRCINTERVENTIONS.115.003153
Salcher M, Naci H, Pender S, Kuehne T, CARDIOPROOF, Kelm M. Surgical Aortic Valve Repair in Patients with Bicuspid Aortic Valve Disease: A Systematic Review and Meta-Analysis. Open Heart. 2016;3:e000502. doi: 10.1136/openhrt-2016-000502
Salcher M, Mcguire AJ, Muthurangu V, Kelm M, Kuehne T, CARDIOPROOF, Naci H. Avoidable costs of stenting for aortic coarctation in the United Kingdom: an economic model. BMC Health Services Research. 2017. ISSN 1472-6963 (In Press).